The production of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex multi-step organic process. Preliminary routes focused on peptide fragment coupling, utilizing solid-phase production methodologies to build the check here long amino acid sequence. Subsequent st… Read More